| Male Breast Carcinoma studied in …STUDIED_INderived104 of 104show fewer |
|---|
| → studied in | NCT03387553early Phase 1 · completed HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05501704Phase 2 · recruiting ETHAN - ET for Male BC · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07558343NA · not yet recruiting Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2 · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00770809Phase 3 · completed Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00861705Phase 2 · completed Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02206334Phase 1 · completed Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07455110completed EORTC Quality of Life Measurement in Males With Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06422455NA · recruiting Access to Genetic Testing in Underserved Patients With Cancer · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03384914Phase 2 · active not recruiting Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01938833Phase 1/Phase 2 · terminated Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01349959Phase 2 · completed Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03800355completed Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01217411Phase 1/Phase 2 · terminated RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05156606NA · terminated Testosterone & Tamoxifen Trial · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01706432completed Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01703520completed Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021). · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096434Phase 2 · completed Sorafenib in Treating Patients With Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01931709NA · terminated FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03018080Phase 2 · completed Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03112590Phase 1/Phase 2 · completed Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02013492early Phase 1 · completed Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03630809Phase 2 · terminated Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1 · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01037790Phase 2 · completed Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470301Phase 1/Phase 2 · completed Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03295695early Phase 1 · withdrawn PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343109Phase 2 · completed Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01355393Phase 1/Phase 2 · completed Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01720602NA · completed Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01783756Phase 1/Phase 2 · completed Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01084057Phase 1 · completed Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869764Phase 2 · completed Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01806675Phase 1/Phase 2 · completed 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01153672NA · completed Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00513695Phase 2 · completed Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01372579Phase 2 · unknown Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063934Phase 1/Phase 2 · terminated Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02580448Phase 1/Phase 2 · completed CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00425672Phase 1/Phase 2 · completed ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01632332Phase 1 · completed Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01638247Phase 3 · completed Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01493310Phase 1 · completed Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02046421Phase 1 · completed Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01394211Phase 2 · terminated Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02060253Phase 1 · completed Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00699491Phase 1/Phase 2 · completed Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01928186NA · completed FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01042535Phase 1/Phase 2 · completed Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01624441Phase 1 · completed Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00821964Phase 2 · completed Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01145430Phase 1 · completed Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118157Phase 2 · completed Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02480933NA · unknown Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01104259Phase 1 · completed Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03240510unknown Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331552Phase 1/Phase 2 · completed Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003199Phase 2 · completed Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343863NA · completed Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01868503Phase 2 · terminated Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01982591completed Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00791037Phase 1/Phase 2 · completed Vaccine Therapy in Treating Patients With Stage IV Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01151449Phase 2 · terminated Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01729884Phase 2 · terminated Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01155258Phase 1 · completed Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01288261Phase 1 · completed Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01276496Phase 1 · completed Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00244881Phase 2 · completed A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202) · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00368875Phase 1/Phase 2 · completed Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01149356Phase 1 · terminated RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01281150Phase 1 · completed Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070252Phase 1/Phase 2 · completed Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450879Phase 1 · terminated Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393105unknown Sense of Hope Alleviates Fatigue in Breast Cancer Survivors · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00132002Phase 2 · terminated Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01131234Phase 1 · completed Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01158274Phase 1 · completed RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068588Phase 2 · completed GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01245205Phase 1 · completed Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01939483NA · withdrawn A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00258349Phase 1/Phase 2 · completed Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077376Phase 2 · completed Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119262Phase 2 · completed Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00559507Phase 2 · completed Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00348699Phase 1 · completed AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01222377NA · terminated Endoscopic Breast Surgery in Treating Patients With Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00071942Phase 1 · terminated Vaccine Therapy in Treating Patients With Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006228Phase 2 · completed Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01705340Phase 1 · terminated Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098605Phase 2 · completed Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028535Phase 1 · completed Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01219907Phase 1 · withdrawn Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089362Phase 1 · completed Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937482Phase 1 · terminated Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030615Phase 1 · completed Decitabine in Treating Patients With Advanced Solid Tumors · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005817Phase 2 · completed Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039455Phase 1 · terminated Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028496Phase 1 · completed Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00024154Phase 2 · completed Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098397Phase 2 · completed FR901228 in Treating Patients With Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045188Phase 2 · completed Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017394Phase 2 · completed Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030498Phase 1 · completed Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095888Phase 2 · terminated 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01100489Phase 2 · withdrawn Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer · condition mapped ALIAS · 104 trials mapped (4 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |